Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group Infected With Severe Acute Respiratory Syndrome Coronavirus 2. (PERSO-COVID)
COVID-19
About this trial
This is an interventional diagnostic trial for COVID-19 focused on measuring COVID-19, coronavirus, SARS-CoV2
Eligibility Criteria
Inclusion Criteria:
- employee aged over 18 years
- employee who participated to the serology tests
- employee who was tested positively to the Covid-19 serology test
- French speaking employee
- employee affiliated to a French social security or any other health insurance system.
- employee who is able to give its free and written consent.
Exclusion Criteria:
- employee under guardianship or curatorship
- employee deprived of liberty
- employee under the protection of justice.
Sites / Locations
- Groupe Hospitalier Paris Saint-Joseph
Arms of the Study
Arm 1
Other
Arm
Serology test results The Paris Saint- Joseph Hospital Group staff was submitted to a 2 times serology test: the 1st took place between April, 20th to May, 12th and the second, between May, 26th to June, 12th. The employees presenting positive antibodies titers to SARS-CoV-2 will be contacted and asked for a 12 month follow-up study organized by the Occupational Health Team and the team of COVID-19 Serology referents appointed to carry out and coordinate the procedure. Each enrolled member will receive a letter with containing an information letter describing the study with a written consent form and a questionnaire enabling the data to be collected individually on the COVID-19 infection.